Mindpeak GmbH

Mindpeak is a Hamburg-based company founded in 2018 that specializes in AI-powered digital pathology solutions aimed at enhancing precision diagnostics, particularly in oncology. The company focuses on analyzing tissue images from various staining methods to provide faster and more accurate pathology results. Mindpeak's mission is to make AI-based microscopical analysis accessible worldwide through its "0-click" solutions, which require no manual configuration and adapt to different lab conditions.

The company offers a suite of CE-IVD-marked and RUO AI algorithms through the Mindpeak AI Console, which allows for instant analysis of uploaded images. Their diagnostic tools include applications for breast cancer and lung PD-L1, along with capabilities for subcellular biomarker quantification and tumor/stroma differentiation. Mindpeak's solutions support routine diagnostics and clinical trials, combining AI with human expertise to ensure accuracy and reproducibility across various platforms. The company has received investment from ZEISS Ventures and collaborates with partners like Techcyte and PathAI to enhance its offerings.